Skip to content

Effect of Marmani Vati Lepa in IV cannula site swelling

An Open Label Single Arm Clinical Study on the Efficacy of the Marmani Vati Lepa in the Management of Superficial Veinous Thrombosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040773
Enrollment
30
Registered
2022-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: Z00-Z99- Factors influencing health status and contact with health services

Interventions

None listed

Sponsors

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinical signs and symptoms of Superficial Venous Thrombosis. 2.Established cases of Superficial Venous Thrombosis in the lower limb and cannula site. 3.Subjects who are ready to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Subjects with HIV, HBsAg and Tuberculosis. 2.Subjects diagnosed with malignancy. 3.Deep Vein Thrombosis.

Design outcomes

Primary

MeasureTime frame
To see the reduction in IV cannula site pain,swelling, tenderness, palpable venous cord.Timepoint: External application at the site of IV cannula (SVT). 2 times per day for 7 days 15 days duration. Assessment on 7th day and 15th Day

Secondary

MeasureTime frame
Suitable clinical scoring of SVT-Visual Infusion Phlebitis score.Timepoint: Local application of Marmani Vati lepa twice daily for 7 days. Visual I Infusion Phalabitis Score 7th day assesment 15th day assessment Duration-15 Days

Countries

India

Contacts

Public ContactDr Pavan Kumar PH

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

drgopiboyapati@gmail.com7892212149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026